Hegland TA, Fang Z, Bucher K
BPC 157 works systemically and indirectly, aiming to fix underlying issues like gut health and inflammation rather than acting on the skin itself
This precision-wellness approach helps distinguish individual variation from true safety concerns, enabling confident, informed treatment decisions
Prime continues to lead industry on GLP-1 research: 1 in 7 stays on GLP-1 drugs for weight loss after two years Real-world, integrated data follows-up on previous insights, analytics
Sources Kraft, S., Buchenauer, L., & Polte, T
The implication: map your offerings to a new daily rhythm that emphasizes satiety, nutrition, and convenience in every bite or sip